Genital Herpes Treatment Market By Drug Type, By Route of Administration, By Indication, By Distribution Channel and by Geography – Opportunities & Forecast, 2018-2025
Genital Herpes Treatment Market By Drug Type (Acyclovir, Valacyclovir and Famciclovir), By Route of Administration (Oral, Topical and Injectable), By Indication (HSV-1 and HSV-2), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Pharmacies an Drug Stores) and by Geography
Genital Herpes Treatment Market is predicted to grow at 4.0% CAGR during the forecast period and estimated to reach at USD 1,661 Million by 2025.
Genital herpes is a sexually transmitted diseases which are caused by viral pathogen, herpes simplex virus (HSV) is carried out via infected people’s semen, saliva and vaginal secretions.: HSV-and HSV-2 are two types of herpes simplex viruses. There are several common symptoms of genital herpes such as blisters on genital organs, blisters in the mouth, lips, etc, itchiness or tingling in the infected areas, pelvic pain, vaginal discharge, etc. Various type of genital herpes treatment such as medication, episodic treatment, and suppressive treatment, etc. Antiviral drugs such as Acyclovir, Famciclovir, and Valacyclovir are commercially available therapeutic for the treatment genital herpes.
To have an edge over the competition by knowing the market dynamics and current trends of “Genital Herpes Treatment Market”, request for Sample Report here
Increasing prevalence of sexually transmitted disease especially genital herpes across the globe is expected to boost the demand of genital herpes treatment over the forecast period. For instance, according to center for disease control and prevention approximately 50 million population affected with genital herpes in the U.S. Factors such as rising diagnosis rate in emerging countries and increasing clinical trial of vaccines for genital herpes has also driven the growth of the genital herpes market during the forecast period. Moreover, increasing awareness about sexually transmitted diseases and rise in government funding to develop innovative therapeutic for the genital herpes treatment spur the market growth during the forecast period. In addition, Accurate diagnostic tests such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, real-time PCR assay are extensively used to diagnose STIs in developed countries. These tests are useful for the diagnosis of asymptomatic infections which would increase the demand for genital herpes treatment and drive the market. However, inadequate reimbursement and low treatment seeking rate for genital herpes, are some of the factors which hinder the growth of the market.
Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report
Various notable players operating in the market, include Novartis AG, GlaxoSmithKline, Genocea Biosciences, AiCuris, Vical, Maruho, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.,, Apotheca Inc., Sandoz Inc., Hospira Inc., Novopharm Ltd., Dr. Reddy’s Laboratories Ltd .among others. Major players are focussing research and development activities to launch innovative therapeutic for the treatment of genital herpes. For instance, GEN-003 vaccines are currently under phase 3 of clinical trial for the treatment of genital herpes infections.
In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here
The global genital herpes treatment market has been segmented on the basis of drug type, route of administration, indication, distribution channel and key geographies. Based on drug type, the market comprises Acyclovir, Valacyclovir and Famciclovir. The research report “global genital herpes treatment market” provides in-depth analysis of global genital herpes treatment market based on drug type, route of administration, indication, distribution channel and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides growth, opportunity, market size, trends and forecast for the global genital herpes treatment market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments, Company share, outlook.
For detailed scope of the “Genital Herpes Treatment Market” report request a Sample Copy of the report
Key questions answered in this research report:
1- At what pace is genital herpes treatment market growing? What will be the global genital herpes treatment market forecast?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in genital herpes treatment and global genital herpes treatment market size?
4- Global genital herpes treatment market outlook, application areas and how they are poised to grow?
5- Global genital herpes treatment market overview, industry analysis and scope of study?
Market Segmentation
By Drug Type
• Acyclovir
• Valacyclovir
• Famciclovir
By Route of Administration
• Oral
• Topical
• Injectable
By Indication
• HSV-1
• HSV-2
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
By Geography
• North America
As a part of customization
o By Drug Type
o By Route of administration
o By Indication
o By Distribution Channel
o US
o Canada
o Mexico
• Europe
As a part of customization
o By Drug Type
o By Route of administration
o By Indication
o By Distribution Channel
o UK
o Germany
o Spain
o Rest of Europe
• Asia-Pacific
As a part of customization
o By Drug Type
o By Route of administration
o By Indication
o By Distribution Channel
o China
o Australia
o India
o Rest of APAC
• ROW
As a part of customization
o By Drug Type
o By Route of administration
o By Indication
o By Distribution Channel
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)
Leading market players
• GlaxoSmithKline
• Genocea Biosciences
• Teva Pharmaceuticals Inc.
• Mylan Pharmaceuticals Inc.,
• Apotheca Inc.,
• Sandoz Inc.,
• Novartis AG,
• Hospira Inc.,
• Novopharm Ltd.,
• Dr. Reddy’s Laboratories Ltd.
*Other prominent players in the market which can be profiled as a part of customization:
• AiCuris
• Vical
• Maruho
Frequently Asked Question About This Report
Genital Herpes Treatment Market [HM33A-00-0719]
Genital Herpes Treatment Market is expected to grow at 4.0% CAGR during the forecast period.
The various distribution channel segments in Genital Herpes Treatment Market include Hospital Pharmacies, Retail Pharmacies, e-Pharmacies and Drug Stores.
The major factors such as rising diagnosis rate in emerging countries and increasing clinical trial of vaccines for genital herpes has driven the growth of the Genital Herpes Market during the forecast period.
The prominent players operating in the Genital Herpes Treatment Market include Novartis AG, GlaxoSmithKline, Genocea Biosciences, AiCuris, Vical, Maruho, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Apotheca Inc., Sandoz Inc., Hospira Inc., Novopharm Ltd., Dr. Reddy’s Laboratories Ltd. among others.
- Published Date: Feb-2020
- Report Format: Excel/PPT
- Report Code: HM33A-00-0719
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Genital Herpes Treatment Market By Drug Type, By Route of Administration, By Indication, By Distribution Channel and by Geography – Opportunities & Forecast, 2018-2025
$ 4,499.00 – $ 6,649.00